Angelalign Technology Inc (06699), the global clear aligner specialist, has unveiled robust results for the six-month period ending June 30, 2026. The company recorded a total of 316,609 case starts during the first half, reflecting a year-on-year growth of 40.2%, while revenue and net profit surged 42.9% and 79.6%, respectively.

This impressive performance is underpinned by a growing appreciation among clinicians for truly patient-centric, clinically driven products and services. Orthodontists are increasingly turning to clear aligners to address complex cases, a task that demands effective, practical tools. Angelalign has responded by refining its solutions for specific indications, simplifying and optimizing clinical workflows, and developing professional systems that empower practitioners to achieve their treatment goals.

Beyond product excellence, the company has cultivated an open, collaborative corporate culture that attracts top talent from diverse backgrounds. United by a shared passion for client clinical success, this team fosters deep global clinical exchange, enabling doctors across different countries and regions to share experiences, learn from one another, and contribute to enhancing Angelalign's product portfolio, software, and services.

This international appeal is reflected in the growing preference for Angelalign's solutions among doctors worldwide, driven by positive clinical outcomes, a comprehensive product range, and predictable treatment results. Dr. Mark Holt of Holt Orthodontics in Northern California, USA, noted, "More than half of our patients undergo clear aligner therapy, and Angelalign's solutions have delivered an exceptional user experience for us."

The international markets excluding mainland China stood out as a particular highlight during the period. Clear aligner case starts in these regions reached 168,001, a 43.4% increase year-on-year, accounting for over half of the company's total cases and achieving profitability. Meanwhile, the mainland China market demonstrated steady share gains, with case numbers climbing 36.8% to 148,608.

Management expresses strong confidence in the company's continued growth capabilities and the accelerating momentum of its global business. "Over the past few years, we have consistently invested in product upgrades, professional education, our direct sales network, and local clinical service teams," commented Angelalign CEO Hu Jiezhang. "These investments are now yielding economies of scale, positioning Angelalign as a trusted partner for orthodontists worldwide. We are deeply grateful for the trust our clients have placed in us. Looking ahead, we are committed to sustaining our growth trajectory and intensifying our focus on innovation and client support."

Founded in 2003, Angelalign Technology Inc is dedicated to supporting dental professionals and patients globally through digitally driven clear aligner technology and services. To date, the company has served over two million cases cumulatively, with a market capitalization of USD 2 billion. As a significant player in the orthodontic industry, Angelalign listed on the Hong Kong Stock Exchange in 2021 and, since initiating its globalization strategy in 2023, has expanded its reach to over 60 countries and regions. More information is available at angelalign.com.

This press release contains forward-looking statements based on current expectations and assumptions, which are subject to risks and uncertainties that could cause actual results to differ materially. Except as required by law, Angelalign undertakes no obligation to update any forward-looking statements due to new information, future events, or other reasons.